Article
High Prevalence of inhA Promoter Mutations among Patients with Drug-Resistant Tuberculosis in KwaZulu-Natal, South Africa.
PloS one - 1 Jan 2015
Niehaus Abraham J, Mlisana Koleka, Gandhi Neel R, Mathema Barun, Brust James C M
Abstract excerpt
BACKGROUND: Drug-resistant tuberculosis (TB) remains extremely difficult to treat because there are often few remaining active medications and limited diagnostic options to detect resistance. Resistance to isoniazid is typically caused by mutations in either katG or the inhA promoter. inhA mutations confer low-level resistance to isoniazid and cross-resistance to ethionamide while katG mutations confer high-level...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
